RecruitingNot ApplicableNCT06885931

Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)

Exploratory Safety and Feasibility Study of Personalized Adaptive Pudendal Neuromodulation for Mixed Urinary Incontinence and Extended Indications Using an Implanted (Picostim IITM) System

Sponsor

Amber Therapeutics Ltd

Enrollment

86 participants

Start Date

Jun 24, 2025

Study Type

INTERVENTIONAL

Conditions

Mixed urinary incontinence Chronic pelvic pain Stress Urinary Incontinence (SUI)Urge Urinary Incontinence

Summary

Exploratory safety and feasibility study of personalized adaptive pudendal neuromodulation for mixed urinary incontinence and extended indications using an implanted (Picostim™ II) system.

Eligibility

Sex: FEMALEMin Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Pudendal neuromodulation for people with chronic pelvic pain, mixed urinary incontinence, and other related conditions. The study is currently recruiting participants at 7 locations. People eligible for this study include women aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.